Suppr超能文献

采用热熔挤出技术制备的聚合物辅助阿立哌唑-己二酸共晶体

Polymer-Assisted Aripiprazole-Adipic Acid Cocrystals Produced by Hot Melt Extrusion Techniques.

作者信息

Butreddy Arun, Sarabu Sandeep, Bandari Suresh, Dumpa Nagireddy, Zhang Feng, Repka Michael A

机构信息

Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, MS 38677, USA.

College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.

出版信息

Cryst Growth Des. 2020 Jul;20(7):4335-4345. doi: 10.1021/acs.cgd.0c00020. Epub 2020 Jun 2.

Abstract

Pharmaceutical cocrystals are a promising strategy to increase the solubility and dissolution rate of poorly soluble drugs. However, their manufacturing process requires a large quantity of solvents. The present study aimed to produce cocrystals by a solvent-free hot melt extrusion (HME) method to improve their solubility and dissolution rate. Aripiprazole (ARP) and adipic acid (ADP) were used as a weakly basic drug and acidic coformer, respectively. The processability of a plain ARP-ADP physical mixture (PM) compared with a PM with 5% Soluplus® (SOL) was investigated. Incorporating 5% SOL into the ARP-ADP blend reduced the processing torque and improved processability. The effects of temperature and screw speed on the formation of cocrystals were studied, and cocrystals were characterized by differential scanning calorimetry (DSC), fourier transform infrared (FTIR) spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, powder X-ray diffraction (PXRD), scanning electron microscopy, and hot-stage microscopy. FTIR spectra revealed noncovalent interaction between ARP and ADP, which was confirmed by NMR spectra. Similarly, PXRD data exhibited characteristic peaks confirming the formation of new crystalline material. Further, the results indicated that cocrystals demonstrated higher dissolution rates and improved compressibility, as well as enhanced flow characteristics compared with pure ARP, suggesting its suitability in the development of solid dosage forms.

摘要

药物共晶体是提高难溶性药物溶解度和溶解速率的一种有前景的策略。然而,它们的制造过程需要大量溶剂。本研究旨在通过无溶剂热熔挤出(HME)方法制备共晶体,以提高其溶解度和溶解速率。分别使用阿立哌唑(ARP)和己二酸(ADP)作为弱碱性药物和酸性共形成物。研究了普通ARP-ADP物理混合物(PM)与含5% Soluplus®(SOL)的PM的可加工性。在ARP-ADP共混物中加入5% SOL可降低加工扭矩并提高可加工性。研究了温度和螺杆转速对共晶体形成的影响,并通过差示扫描量热法(DSC)、傅里叶变换红外(FTIR)光谱、核磁共振(NMR)光谱、粉末X射线衍射(PXRD)、扫描电子显微镜和热台显微镜对共晶体进行了表征。FTIR光谱揭示了ARP和ADP之间的非共价相互作用,NMR光谱证实了这一点。同样,PXRD数据显示出特征峰,证实了新晶体材料的形成。此外,结果表明,与纯ARP相比,共晶体表现出更高的溶解速率、更好的可压缩性以及增强的流动特性,表明其适用于固体剂型的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d0/8081332/5d8837c4b315/nihms-1688083-f0002.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验